Chiappini, Stefania

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions

Schifano, F., Chiappini, S., Corkery, J. M., & Guirguis, A. (2019) · International Journal of Neuropsychopharmacology

Pharmacovigilance and Adverse Drug ReactionsSubstance Abuse Treatment and Outcomes

Cited by 194

A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency’s ‘Suspected Adverse Drug Reactions’ Database

Chiappini, S., & Schifano, F. (2016) · CNS Drugs

Opioid Use Disorder TreatmentPharmacovigilance and Adverse Drug Reactions

Cited by 189

New/emerging psychoactive substances and associated psychopathological consequences

Schifano, F., Napoletano, F., Chiappini, S., Guirguis, A., Corkery, J. M., Bonaccorso, S., Ricciardi, A., Scherbaum, N., & Vento, A. (2021) · Psychological Medicine

Forensic Toxicology and Drug AnalysisPsychedelics and Drug Studies

Cited by 119

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset

Chiappini, S., Vickers-Smith, R., Harris, D., Papanti Pelletier, G. D., Corkery, J. M., Guirguis, A., Martinotti, G., Sensi, S. L., & Schifano, F. (2023) · Pharmaceuticals

Pharmacovigilance and Adverse Drug ReactionsPharmacology and Obesity Treatment

Cited by 78

Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems

Schifano, F., Chiappini, S., Corkery, J. M., & Guirguis, A. (2019) · Frontiers in Pharmacology

Pharmacovigilance and Adverse Drug ReactionsOpioid Use Disorder Treatment

Cited by 55

Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports

Schifano, F., & Chiappini, S. (2018) · PLOS ONE

Pharmacovigilance and Adverse Drug ReactionsPoisoning and overdose treatments

Cited by 44

Is There a Potential of Misuse for Quetiapine?: Literature Review and Analysis of the European Medicines Agency/European Medicines Agency Adverse Drug Reactions' Database

Chiappini, S., & Schifano, F. (2018) · Journal of Clinical Psychopharmacology

Pharmacovigilance and Adverse Drug ReactionsSchizophrenia research and treatment

Cited by 44

Is There a Potential of Misuse for Venlafaxine and Bupropion?

Schifano, F., & Chiappini, S. (2018) · Frontiers in Pharmacology

Pharmacovigilance and Adverse Drug ReactionsOpioid Use Disorder Treatment

Cited by 38

Pregabalin: A range of misuse‐related unanswered questions

Schifano, F., & Chiappini, S. (2019) · CNS Neuroscience & Therapeutics

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 36

Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database

Chiappini, S., Schifano, F., Corkery, J. M., & Guirguis, A. (2020) · Brain Sciences

Pharmacovigilance and Adverse Drug ReactionsSchizophrenia research and treatment

Cited by 33